Catalyst Wire Dossier Catalyst Wire Dossier

GW572016

lapatinib · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GW572016, covering 2012-03-07 to 2014-07-10. Get the full timeline:

Most recent: Clinical Trial Update: GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin [Phase 2]

See pricing